Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Robbins

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
JAMA|October 2, 2003
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trialJane A Cauley, John Robbins, Zhao Chen, et al.
Contemporary Clinical Trials|April 22, 2006
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementiaSteven T DeKosky, Annette Fitzpatrick, Diane G Ives, et al.
Journal of the Air & Waste Management Association (1995)|April 6, 2004
Impact of engine lubricant properties on regulated gaseous emissions of 2000-2001 model-year gasoline vehiclesThomas D Durbin, Claudia G Sauer, John T Pisano, et al.
Archives of Internal Medicine|April 27, 2011
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational StudyVanessa L Jacoby, Deborah Grady, Jean Wactawski-Wende, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2013
Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health studyAnna Jovanovich, Petra Bùzková, Michel Chonchol, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Obstetrics and Gynecology|December 8, 2016
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled TrialPeter F Schnatz, Xuezhi Jiang, Aaron K Aragaki, et al.
The New England Journal of Medicine|June 22, 2007
Estrogen therapy and coronary-artery calcificationJoann E Manson, Matthew A Allison, Jacques E Rossouw, et al.
The New England Journal of Medicine|June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal womenPaul E Goss, James N Ingle, José E Alés-Martínez, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2013
Association of DXA-derived bone mineral density and fat mass with African ancestryHeather M Ochs-Balcom, Leah Preus, Jean Wactawski-Wende, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
JAMA|October 2, 2003
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trialJane A Cauley, John Robbins, Zhao Chen, et al.
Contemporary Clinical Trials|April 22, 2006
The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementiaSteven T DeKosky, Annette Fitzpatrick, Diane G Ives, et al.
Journal of the Air & Waste Management Association (1995)|April 6, 2004
Impact of engine lubricant properties on regulated gaseous emissions of 2000-2001 model-year gasoline vehiclesThomas D Durbin, Claudia G Sauer, John T Pisano, et al.
Archives of Internal Medicine|April 27, 2011
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational StudyVanessa L Jacoby, Deborah Grady, Jean Wactawski-Wende, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2013
Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health studyAnna Jovanovich, Petra Bùzková, Michel Chonchol, et al.
The Lancet. Oncology|February 10, 2012
Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung, Lianne Tile, Savannah Cardew, et al.
Obstetrics and Gynecology|December 8, 2016
Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled TrialPeter F Schnatz, Xuezhi Jiang, Aaron K Aragaki, et al.
The New England Journal of Medicine|June 22, 2007
Estrogen therapy and coronary-artery calcificationJoann E Manson, Matthew A Allison, Jacques E Rossouw, et al.
The New England Journal of Medicine|June 7, 2011
Exemestane for breast-cancer prevention in postmenopausal womenPaul E Goss, James N Ingle, José E Alés-Martínez, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2013
Association of DXA-derived bone mineral density and fat mass with African ancestryHeather M Ochs-Balcom, Leah Preus, Jean Wactawski-Wende, et al.
Pageof 8